Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35 (2013), Issue 1, Pages 23–31
http://dx.doi.org/10.1155/2013/984845
Review Article

Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?

Max Planck Institute of Psychiatry, Molecular Stress Physiology, Kraepelinstrasse 2-10, 80804 Munich, Germany

Received 1 April 2013; Accepted 19 April 2013

Academic Editor: Daniel Martins-de-Souza

Copyright © 2013 Christiana Labermaier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • Daniel Martins-de-Souza, Giuseppina Maccarrone, Marcus Ising, Stefan Kloiber, Susanne Lucae, Florian Holsboer, and Christoph W. Turck, “Blood mononuclear cell proteome suggests Integrin and Ras signaling as critical pathways for antidepressant treatment response,” Biological Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Mayuresh S. Korgaonkar, William Rekshan, Evian Gordon, A. John Rush, Leanne M. Williams, Christine Blasey, and Stuart M. Grieve, “Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder,” EBioMedicine, 2014. View at Publisher · View at Google Scholar
  • P. Gorwood, K. Demyttenare, G. Vaiva, E. Corruble, P.M. Llorca, F. Bayle, and P. Courtet, “An increase in joy after two weeks Is more specific of later antidepressant response than a decrease in sadness.,” Journal of Affective Disorders, 2015. View at Publisher · View at Google Scholar
  • Eva E. Redei, and Neha S. Mehta, “Blood transcriptomic markers for major depression: from animal models to clinical settings,” Annals of the New York Academy of Sciences, 2015. View at Publisher · View at Google Scholar
  • Yogesh Dwivedi, “Pathogenetic and therapeutic application of microRNAs in major depressive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Eugene Lin, and Shih-Jen Tsai, “Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Mahdi Mohammadi, Fadwa Al-Azab, Bijan Raahemi, Gregory Richards, Natalia Jaworska, Dylan Smith, Sara de la Salle, Pierre Blier, and Verner Knott, “Data mining EEG signals in depression for their diagnostic value,” BMC Medical Informatics and Decision Making, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Y Dwivedi, B Roy, G Lugli, H Rizavi, H Zhang, and N R Smalheiser, “Chronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiology,” Translational Psychiatry, vol. 5, no. 11, pp. e682, 2015. View at Publisher · View at Google Scholar
  • Georgia Balsevich, Christian Namendorf, Tamara Gerlach, Manfred Uhr, and Mathias V. Schmidt, “The bio-distribution of the antidepressant clomipramine is modulated by chronic stress in mice: effects on behavior,” Frontiers in Behavioral Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Jakub Kazmierski, Tomasz Sobáw, and Monika Radziszewska, “EEG and QEEG biomarkers as predictors of antidepressant treatment response,” Psychiatria i Psychologia Kliniczna, vol. 15, no. 1, pp. 19–25, 2015. View at Publisher · View at Google Scholar
  • Bun-Hee Lee, Young-Min Park, Seung-Hwan Lee, and Miseon Shim, “Prediction of Long-Term Treatment Response to Selective Serotonin Reuptake Inhibitors (SSRIs) Using Scalp and Source Loudness Dependence of Auditory E,” International Journal Of Molecular Sciences, vol. 16, no. 3, pp. 6251–6265, 2015. View at Publisher · View at Google Scholar
  • Bhaskar Roy, Michael Dunbar, Richard C Shelton, and Yogesh Dwivedi, “Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder,” Neuropsychopharmacology, vol. 42, no. 4, pp. 864–875, 2016. View at Publisher · View at Google Scholar
  • Kristi Pettai, Lili Milani, Anu Tammiste, Urmo Võsa, Raivo Kolde, Triin Eller, David Nutt, Andres Metspalu, and Eduard Maron, “Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression,” European Neuropsychopharmacology, 2016. View at Publisher · View at Google Scholar
  • Ke Ma, Hongxiu Zhang, and Zulqarnain Baloch, “Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review,” International Journal of Molecular Sciences, vol. 17, no. 5, pp. 733, 2016. View at Publisher · View at Google Scholar
  • Indira Mendez-David, Céline Boursier, Valérie Domergue, Romain Colle, Bruno Falissard, Emmanuelle Corruble, Alain M. Gardier, Jean-Philippe Guilloux, and Denis J. David, “Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression,” Frontiers in Cellular Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar
  • Martin Bares, Tomas Novak, Martin Brunovsky, Miloslav Kopecek, and Cyril Höschl, “The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder,” The Journal of Nervous and Mental Disease, vol. 205, no. 8, pp. 618–626, 2017. View at Publisher · View at Google Scholar
  • Stefanie Wagner, Alice Engel, Jan Engelmann, David Herzog, Nadine Dreimüller, Marianne B. Müller, André Tadić, and Klaus Lieb, “Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis,” Journal of Psychiatric Research, 2017. View at Publisher · View at Google Scholar
  • Maria Fernandes, David Mutch, and Francesco Leri, “The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants,” Nutrients, vol. 9, no. 3, pp. 298, 2017. View at Publisher · View at Google Scholar
  • Raoul Belzeaux, Rixing Lin, and Gustavo Turecki, “Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants,” CNS Drugs, vol. 31, no. 4, pp. 253–262, 2017. View at Publisher · View at Google Scholar